Results 291 to 300 of about 113,489 (310)
Some of the next articles are maybe not open access.
Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients
Annals of Neurology, 2016Peter Martus +2 more
exaly +2 more sources
Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum [PDF]
Autosomal recessive hereditary spastic paraplegia (ARHSP) with thin corpus callosum (TCC) is a common and clinically distinct form of familial spastic paraplegia that is linked to the SPG11 locus on chromosome 15 in most affected families. We analyzed
Giovanni Stevanin +2 more
exaly +2 more sources
Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia — The SPASTOX Trial
Movement Disorders, 2021Hereditary spastic paraplegia presents spasticity as the main clinical manifestation, reducing gait quality and producing incapacity. Management with botulinum toxin type A (BoNT‐A) is not well elucidated.
Fabricio Diniz de Lima +11 more
semanticscholar +1 more source
Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism
Movement Disorders, 2019Pathogenic variants in the spastic paraplegia type 7 gene cause a complicated hereditary spastic paraplegia phenotype associated with classical features of mitochondrial diseases, including ataxia, progressive external ophthalmoplegia, and deletions of ...
B. De la Casa-Fages +26 more
semanticscholar +1 more source
Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia
Brain, 2022Jean-Loup Méreaux +2 more
exaly
IEEE transactions on neural systems and rehabilitation engineering, 2016
Kevin H. Ha +2 more
semanticscholar +1 more source
Kevin H. Ha +2 more
semanticscholar +1 more source
Hereditary spastic paraplegia.
Handbook of Clinical Neurology, 2018C. Blackstone
semanticscholar +1 more source
Hereditary spastic paraplegia: More than an upper motor neuron disease.
Revue neurologique (Paris), 2017L. Parodi +4 more
semanticscholar +1 more source

